Composition
- Active ingredients
- ATAZANAVIR SULFATE EQ 300MG BASE; COBICISTAT 150MG
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA206353.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Evotaz
- Active substance
- atazanavir sulfate
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Bristol
- Status
- Prescription
- FDA approval
- 29 Jan 2015
- Application
- NDA206353-001